Skip to main content
AAO-HNSF 2026 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Expert Lecture

Rhinology/Allergy

Control of Chronic Rhinosinusitis: What It Is, How to Measure It and Use in Practice

Saturday, October 17, 2026
4:00 PM - 5:00 PM PT
Location: Theatre 411

    Lead Presenter(s)

  • AS

    Ahmad R. Sedaghat, MD, PhD, FACS

    Professor, Executive Vice Chair, Director of Div. of Rhinology, Allergy& Anterior Skull Base Surgery
    UC Health/University of Cincinnati College of Medicine
    Cincinnati, Ohio, United States

    • Co-Presenter(s)

  • SG

    Stacey T. Gray, MD, FACS

    Associate Professor, Vice Chair for Education
    Mass. Eye and Ear / Harvard Medical School
    Boston, Massachusetts, United States

In this presentation, we will summarize the most up to date literature on discrete outcome measures that serve as criteria for assessing CRS
disease control. We will discuss the significance of these outcome measures from the perspective of the patients and healthcare providers from maximizing patient satisfaction and quality of life, the perspective of medical necessity and the perspective of society at large. We will then describe evidence-based ways to use metrics of CRS disease control that can be very easily measured/assessed to guide treatment of CRS in the real-world setting. This lecture will therefore increase the attendee’s potential for successful treatment of CRS -- by seeking specific outcomes exemplifying disease control and titrating treatment to achieve long term CRS disease control.

Learning Objectives:

  • Demonstrate knowledge of practical, discrete, and independent manifestations and sequelae of chronic rhinosinusitis that should be considered to assess a patient's chronic rhinosinusitis disease control.
  • Measure, quantify, and classify a CRS patient's level of disease control in a manner that will directly inform that patient's clinical care.
  • Implement treatments to specifically target elements of chronic rhinosinusitis (CRS) disease control related to patient-centered (e.g.satisfaction or quality of life), provider-driven, and economic outcomes to successful control a patient's CRS.